The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health
Open accessAbstract
Expanding epidemiologic and physiologic data suggest that urinary stone disease is best conceptualized as a chronic metabolic condition punctuated by symptomatic, preventable stone events. These acute events herald substantial future chronic morbidity, including decreased bone mineral density, cardiovascular disease, and CKD. Urinary stone disease imposes a large and growing public health burden. In the United States, 1 in 11 individuals will experience a urinary stone in their lifetime. Given this high incidence and prevalence, urinary stone disease is one of the most expensive urologic conditions, with health care charges exceeding $10 billion annually. Patient care focuses on management of symptomatic stones rather than prevention; after three decades of innovation, procedural interventions are almost exclusively minimally invasive or noninvasive, and mortality is rare. Despite these advances, the prevalence of stone disease has nearly doubled over the past 15 years, likely secondary to dietary and health trends. The NIDDK recently convened a symposium to assess knowledge and treatment gaps to inform future urinary stone disease research. Reducing the public health burden of urinary stone disease will require key advances in understanding environmental, genetic, and other individual disease determinants; improving secondary prevention; and optimal population health strategies in an increasingly cost–conscious care environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Clark, M. A., & Fox, M. K. (2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.10.060 · Cited by 189
Moore, C. L., Bomann, S., Daniels, B., Luty, S., Molinaro, A., Singh, D., & Gross, C. P. (2014) · BMJ · doi:10.1136/bmj.g2191 · Cited by 157
Cited by
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J.-A., Fogo, A. B., Fox, C. S., Gansevoort, R. T., Heerspink, H. J. L., Jardine, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30788-2 · Cited by 919
An overview of kidney stone imaging techniques
Brisbane, W., Bailey, M. R., & Sorensen, M. D. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2016.154 · Cited by 391
Reducing major risk factors for chronic kidney disease
Luyckx, V. A., Tuttle, K. R., Garcia-Garcia, G., Gharbi, M. B., Heerspink, H. J. L., Johnson, D. W., Liu, Z.-H., Massy, Z. A., Moe, O., Nelson, R. G., et al. (2017) · Kidney International Supplements · doi:10.1016/j.kisu.2017.07.003 · Cited by 254
Bejan, C. A., Reed, A. M., Mikula, M., Zhang, S., Xu, Y., Fabbri, D., Embí, P. J., & Hsi, R. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-86632-5 · Cited by 8
Metadata
- Authors
- Scales, C. D., Tasian, G. E., Schwaderer, A. L., Goldfarb, D. S., Star, R. A., & Kirkali, Z.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2016-03-10
- Volume
- 11
- Issue
- 7
- Pages
- 1305-1312
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2295718378
- Cited by
- 182
- References
- 3
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health. https://app.cochat.ai/papers/10.2215/cjn.13251215
- The paper
- Scales, C. D., Tasian, G. E., Schwaderer, A. L., Goldfarb, D. S., Star, R. A., & Kirkali, Z. (2016). Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.13251215
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.